Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$199 USD / Month *
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you Statistics on
About the industry
9
- Basic Statistic COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
- Basic Statistic COVID-19 vaccine comparison Biontech/Pfizer vs Moderna 2020
- Premium Statistic Select COVID-19 vaccine pricing and funding as of August 2020
- Basic Statistic Major COVID-19 vaccines by number of countries using them March 2021
- Basic Statistic COVID-19 vaccines by contract size in doses by country and manufacturer 2021
- Basic Statistic COVID-19 vaccine dose numbers by top manufacturer 2021
- Basic Statistic COVID-19 vaccines contract size in doses by country and region 2021
- Basic Statistic Market reaction of COVID-19 vaccine makers to U.S. support of vaccine patents waiver
- Basic Statistic Leading COVID-19 drugs, therapies and vaccines in development by early results 2020
About the region
10
- Basic Statistic COVID-19 vaccine dose rate worldwide by select country or territory March 20, 2023
- Basic Statistic Launch disruption on global pharmaceutical market due to coronavirus 2020-2025
- Premium Statistic Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- Premium Statistic Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Basic Statistic Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019
- Basic Statistic Revenue of BioNTech 2017-2023
- Basic Statistic Moderna's revenue 2016-2023
- Basic Statistic Moderna total assets 2016-2023
- Basic Statistic Moderna net income 2016-2023
- Basic Statistic R&D expenses of Moderna 2016-2023
Selected statistics
4
Other regions
10
- Basic Statistic Confirmed COVID-19 vaccine doses for Germany 2021, by manufacturer
- Basic Statistic COVID-19 vaccine and willingness among U.S. adults Dec 2020 - Apr 2022
- Basic Statistic Confirmed COVID-19 vaccine doses for Finland 2021-2022, by manufacturer
- Basic Statistic Number of COVID-19 hospitalizations in Canada as of May 2, 2023, by age
- Basic Statistic Coronavirus (COVID-19) vaccination rate APAC June 2023, by country
- Basic Statistic COVID-19 vaccine adverse events in Spain 2022, by manufacturer
- Basic Statistic Adverse effect cases seriousness of vaccines against Covid-19 in France 2021
- Basic Statistic COVID-19 vaccines confirmed doses in Mexico 2022, by producer
- Basic Statistic Number of applications for clinical trials in Norway 2008-2021
- Basic Statistic Number of COVID-19 vaccines ordered and delivered by Australia as of October 2021
Related statistics
10
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Basic Statistic Total vaccine related funding by the National Institutes for Health 2013-2024
- Basic Statistic Moderna Inc collaboration revenue by related party 2018-2023
- Basic Statistic R&D expenses of Moderna by type 2023
- Premium Statistic Leading pharmaceutical companies by global vaccine revenue 2021
- Basic Statistic Top challenges for pharmaceutical companies during COVID-19 2020
- Basic Statistic YTD stock performance of biopharma companies working on COVID March 2020
- Premium Statistic Total global vaccine market size forecast 2028
- Basic Statistic Percent of registered clinical studies worldwide by type 2024
- Basic Statistic COVID-19 vaccinations administered in the U.S. as of April 2023, by manufacturer
Further related statistics
10
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- GSK's operating profit by division 2006-2021
- Sanofi's total assets 2007-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Number of employees at Sinopharm 2011-2022
Further Content: You might find this interesting as well
Statistics
- Merck & Co - expenditure on research and development 2006-2023
- Merck & Co cash dividends declared 2006-2023
- Merck & Co total assets 2009-2023
- Pfizer's revenues in the U.S. and abroad 2009-2023
- AstraZeneca's expenditure on research and development 2006-2023
- GSK's operating profit by division 2006-2021
- Sanofi's total assets 2007-2023
- AstraZeneca's revenue from top product Pulmicort 2006-2023
- Sales of Johnson & Johnson 2006-2023 by region
- Number of employees at Sinopharm 2011-2022
The Guardian. (March 6, 2021). Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 [Graph]. In Statista. Retrieved April 29, 2024, from https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. "Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023." Chart. March 6, 2021. Statista. Accessed April 29, 2024. https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. (2021). Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023. Statista. Statista Inc.. Accessed: April 29, 2024. https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. "Prices and Sales Forecasts for Major Covid-19 Vaccines from 2021 to 2023." Statista, Statista Inc., 6 Mar 2021, https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian, Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 Statista, https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/ (last visited April 29, 2024)
Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 [Graph], The Guardian, March 6, 2021. [Online]. Available: https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/